Skip to main content
OpenTrials

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,146 public trials 2,034 recruiting studies
Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Recruiting

Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma

NCT04234048

Conditions
Angioimmunoblastic T-cell Lymphoma, Cutaneous T-Cell Lymphoma, Cutaneous T-Cell Lymphoma, Unspecified, +23 more
Locations
  • Mayo Clinic Arizona Scottsdale, Arizona, United States
  • City of Hope Medical Foundation Duarte, California, United States
  • University of Southern California Los Angeles, California, United States
  • University of Colorado Anschutz Medical Campus Aurora, Colorado, United States
View Trial Details
Recruiting

REmote iSchemic condItioning in Lymphoma PatIents REceiving ANthraCyclinEs

NCT05223413

Conditions
Anthracycline-induced Cardiac Toxicity, Hemic and Lymphatic Diseases, Immune System Diseases, +6 more
Locations
  • Aarhus University Aarhus, Denmark
  • Hospital Jaques Monod, El Havre Montivilliers, France
  • Henri Becquerel Rouen, France
  • University Hospital Duesseldorf UDUS Düsseldorf, Germany
View all 24 locations
View Trial Details
Recruiting

HEME Home Transfusion Program

NCT06487247

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hematologic Malignancy, +14 more
Locations
  • Brigham and Women's Hospital Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Recruiting

HEM-iSMART-C: Ruxolitinib + Venetoclax + Dexamethasone + Cyclophosphamide and Cytarabine in Pediatric Patients With Relapsed or Refractory Hematological Malignancies

NCT05745714

Conditions
Acute Lymphoblastic Leukemia, in Relapse, Disease Attributes, Hematologic Diseases, +19 more
Locations
  • St. Anna Kinderspital Vienna, Austria
  • Universitair Ziekenhuis Gent Ghent, Belgium
  • Rigshospitalet Copenhagen Copenhagen, Denmark
  • Helsinki University Hospital, New Children's Hospital Helsinki, Finland
View all 33 locations
View Trial Details
Recruiting

HEM iSMART-D: Trametinib + Dexamethasone + Chemotherapy in Children With Relapsed or Refractory Hematological Malignancies

NCT05658640

Conditions
Acute Lymphoblastic Leukemia, in Relapse, Disease Attributes, Hematologic Diseases, +19 more
Locations
  • St. Anna Kinderspital Vienna, Austria
  • Universitair Ziekenhuis Gent Ghent, Belgium
  • Rigshospitalet Copenhagen Copenhagen, Denmark
  • Helsinki University Hospital, New Children's Hospital Helsinki, Finland
View all 36 locations
View Trial Details

Related conditions